BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 7630628)

  • 1. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel, activated RAS mutations alter protein-protein interactions.
    Dalley BK; Cannon JF
    Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
    Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
    Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
    Barnard D; Diaz B; Hettich L; Chuang E; Zhang XF; Avruch J; Marshall M
    Oncogene; 1995 Apr; 10(7):1283-90. PubMed ID: 7731678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
    Warne PH; Viciana PR; Downward J
    Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
    Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S
    Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf.
    Filchtinski D; Sharabi O; Rüppel A; Vetter IR; Herrmann C; Shifman JM
    J Mol Biol; 2010 Jun; 399(3):422-35. PubMed ID: 20361980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S; Bottorff D; Stone JC
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
    Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
    Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW
    Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
    Arai H; Escobedo JA
    Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor.
    Chen SY; Huff SY; Lai CC; Der CJ; Powers S
    Oncogene; 1994 Sep; 9(9):2691-8. PubMed ID: 8058333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential effects of the Gly-60 to Ala mutation on the interaction of H-Ras p21 with different downstream targets.
    Hwang MC; Sung YJ; Hwang YW
    J Biol Chem; 1996 Apr; 271(14):8196-202. PubMed ID: 8626511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
    Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAF protein-serine/threonine kinases: structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2010 Aug; 399(3):313-7. PubMed ID: 20674547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase.
    Moodie SA; Willumsen BM; Weber MJ; Wolfman A
    Science; 1993 Jun; 260(5114):1658-61. PubMed ID: 8503013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.